Adamas Pharmaceuticals Inc·4

Dec 29, 7:40 PM ET

Adamas Pharmaceuticals Inc 4

4 · Adamas Pharmaceuticals Inc · Filed Dec 29, 2014

Insider Transaction Report

Form 4
Period: 2014-12-24
Transactions
  • Sale

    Common Stock

    2014-12-24$17.51/sh2,000$35,02051,778 total
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_551377

    POA DOCUMENT